About Company
- Legal Name: ARCALIS, Inc.
- Registered country: Japan
- Address: 226-39, Wakashiba,,, Kashiwa Shi
- Number of employees: 100 - 249
Description:
A CDMO specializing in mRNA medicines and vaccines, founded by Axcelead (Japan's first drug discovery platform) and Arcturus Therapeutics (a US mRNA company). In 2023, ARCALIS opened a GMP mRNA drug substance facility in Japan, and in 2024 achieved the world's first commercial production of a self-amplifying mRNA COVID-19 vaccine, supporting clients from early research through commercial production across rare diseases, oncology, regenerative medicine and genome editing.
Business Activities
ATC (Anatomical Therapeutic Chemical) Classification
Contract Manufacturer
Our Products & Services
Certifications
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment